HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daniel M DeLaughter Selected Research

Daniel M DeLaughter Research Topics

Disease

3Fibrosis (Cirrhosis)
12/2022 - 12/2017
2Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy)
01/2023 - 12/2022
1Heart Failure
01/2023
1Stroke (Strokes)
01/2023
1Cardiac Sudden Death (Sudden Cardiac Arrest)
01/2023
1Cardiomegaly (Heart Hypertrophy)
12/2022
1Congenital Microtia
01/2022
1Aortic Valve Disease
01/2018
1Disease Progression
01/2018
1Aneurysm (Aneurysms)
10/2017
1Inflammation (Inflammations)
10/2017
1Hypertension (High Blood Pressure)
10/2017
1Rupture
10/2017
1Heart Diseases (Heart Disease)
10/2017
1Aortic Rupture
10/2017

Drug/Important Bio-Agent (IBA)

1Cardiac MyosinsIBA
01/2023
1AcidsIBA
12/2022
1lysophosphatidic acidIBA
12/2022
1Cell Surface ReceptorsIBA
12/2022
1Lysophosphatidic Acid ReceptorsIBA
12/2022
1Myosin Heavy Chains (Myosin Heavy Chain)IBA
12/2022
1ElementsIBA
01/2022
1Intergenic DNA (Junk DNA)IBA
01/2022
1Proteins (Proteins, Gene)FDA Link
01/2018
1ProteomeIBA
01/2018
1Glial Fibrillary Acidic ProteinIBA
01/2018
1Interleukin-11 (Interleukin 11)IBA
12/2017
1Angiotensin IIIBA
10/2017
1Norepinephrine (Noradrenaline)FDA LinkGeneric
10/2017
1RNA (Ribonucleic Acid)IBA
10/2017
1Reactive Oxygen Species (Oxygen Radicals)IBA
10/2017

Therapy/Procedure

1Therapeutics
01/2018